Can-Fite BioPharma Ltd.
Hedge Funds Holdings
Last updated:
Can-Fite BioPharma Ltd.‘s stocks are currently a part of 4 hedge funds’ portfolios, which represents 0.01% of the total amount of its stocks outstanding. This makes up a total of 4.86K shares of Can-Fite BioPharma Ltd.. Compared to the previous quarter, the number fell by -88.60% or -37.84K shares fewer. As for the holding position changes, 150% (6) closed the holdings completely. 4 hedge funds are new holders of Can-Fite BioPharma Ltd. stock in Q1 2023, it is 100% of total holders.
Hedge funds holding Can-Fite BioPharma Ltd. (Q2 2018 – Q1 2023)
| Q2 2018 | 11 |
|---|---|
| Q3 2018 | 10 |
| Q4 2018 | 6 |
| Q1 2019 | 6 |
| Q2 2019 | 5 |
| Q3 2019 | 3 |
| Q4 2019 | 5 |
| Q1 2020 | 3 |
| Q2 2020 | 7 |
| Q3 2020 | 8 |
| Q4 2020 | 5 |
| Q1 2021 | 11 |
| Q2 2021 | 10 |
| Q3 2021 | 11 |
| Q4 2021 | 13 |
| Q1 2022 | 10 |
| Q2 2022 | 10 |
| Q3 2022 | 10 |
| Q4 2022 | 9 |
| Q1 2023 | 4 |
Hedge funds changes in Can-Fite BioPharma Ltd. positions (Q2 2018 – Q1 2023)
| Q2 2018 | 6 | 1 | 1 | 5 | -2 |
|---|---|---|---|---|---|
| Q3 2018 | 3 | 1 | 2 | 4 | 0 |
| Q4 2018 | 0 | 3 | 0 | 4 | -1 |
| Q1 2019 | 1 | 2 | 1 | 1 | 1 |
| Q2 2019 | 5 | 0 | 0 | 5 | -5 |
| Q3 2019 | 2 | 0 | 1 | 4 | -4 |
| Q4 2019 | 4 | 0 | 1 | 2 | -2 |
| Q1 2020 | 1 | 1 | 1 | 3 | -3 |
| Q2 2020 | 5 | 0 | 2 | 1 | -1 |
| Q3 2020 | 5 | 2 | 1 | 4 | -4 |
| Q4 2020 | 1 | 3 | 0 | 4 | -3 |
| Q1 2021 | 9 | 1 | 1 | 3 | -3 |
| Q2 2021 | 2 | 1 | 3 | 3 | 1 |
| Q3 2021 | 5 | 1 | 1 | 4 | 0 |
| Q4 2021 | 4 | 1 | 1 | 2 | 5 |
| Q1 2022 | 3 | 1 | 0 | 6 | 0 |
| Q2 2022 | 2 | 2 | 0 | 2 | 4 |
| Q3 2022 | 1 | 2 | 2 | 1 | 4 |
| Q4 2022 | 1 | 1 | 3 | 1 | 3 |
| Q1 2023 | 4 | 0 | 0 | 6 | -6 |
Hedge funds changes in Can-Fite BioPharma Ltd. stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 25,000 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |
Top 50 hedge fund holders of Can-Fite BioPharma Ltd. (AMEX:CANF)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| MORGAN STANLEY | 247K | 320.17K | 0.000% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 46K | 59.37K | 0.000% |
| FIFTH THIRD BANCORP | 23K | 30K | 0.000% |
| VIRTU FINANCIAL LLC | 22K | 28.77K | 0.002% |
| UBS GROUP AG | 13K | 17.36K | 0.000% |
| TWO SIGMA SECURITIES, LLC | 11K | 14.57K | 0.000% |
| STIFEL FINANCIAL CORP | 9K | 12K | 0.000% |
| NATIONAL BANK OF CANADA /FI/ | 4K | 6K | 0.000% |
| CITIGROUP INC | 4K | 5.53K | 0.000% |
| CAPTRUST FINANCIAL ADVISORS | 0 | 0 | 0.000% |